In 2001, autologous DCs pulsed with tumor antigen melanoma-associated antigen 3 (MAGE-3), commonly expressed in advanced BC, was synthesized to bind specifically to HLA-A24. This evidence concerns the gene MAGEA3 and breast cancer.